Gu, Z. ., Gasperoni, F. ., Paige, E. ., Sweeting, M. ., Usher-Smith, J. ., Poppe, K. ., … Barrett, J. K. (2025). Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study. BMJ Public Health, 3, e001241. http://doi.org/10.1136/bmjph-2024-001241
cardiovascular diseases
Downes, T. J., Guthrie, B. ., Moreno-Martos, D. ., & Morales, D. R. (2025). Health conditions in adults with atrial fibrillation compared with the general population: a population-based cross-sectional analysis. Heart. http://doi.org/10.1136/heartjnl-2024-324618
Critchley, J. A., Limb, E. S., Khakharia, A. ., Carey, I. M., Auld, S. C., DeWilde, S. ., … Magee, M. J. (2024). Tuberculosis and increased incidence of cardiovascular disease: Cohort study using US and UK health records. Clin Infect Dis. http://doi.org/10.1093/cid/ciae538
Qureshi, N. ., Woods, B. ., de Faria, N. ., Goncalves, S. ., Cox, E. ., Bee, L. ., … Kai, J. . (2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technol Assess, 27, 1–140. http://doi.org/10.3310/ctmd0148
Yu, D. ., Huang, X. ., Mamas, M. A., & Wilkie, R. . (2023). Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992-2017. RMD Open, 9. http://doi.org/10.1136/rmdopen-2023-003298